AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI)

CUSIP: 00901B105

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
67,129,058
Total 13F shares
5,772,330
Share change
-229,642
Total reported value
$3,360,006
Price per share
$0.58
Number of holders
27
Value change
-$143,308
Number of buys
5
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 00901B105?
CUSIP 00901B105 identifies AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
3%
1,987,595
$1,550,000 30 Jun 2022
13F
MORGAN STANLEY
13F
Company
2.4%
1,599,304
$1,248,000 30 Jun 2022
13F
BlackRock Finance, Inc.
13F
Company
1.2%
816,702
$638,000 30 Jun 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.57%
382,014
$297,000 30 Jun 2022
13F
STATE STREET CORP
13F
Company
0.26%
173,103
$135,000 30 Jun 2022
13F
Verition Fund Management LLC
13F
Company
0.23%
153,002
$119,000 30 Jun 2022
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.22%
151,000
$118,000 30 Jun 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.18%
120,408
$94,000 30 Jun 2022
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.17%
116,800
$91,000 30 Jun 2022
13F
NORTHERN TRUST CORP
13F
Company
0.13%
88,707
$69,000 30 Jun 2022
13F
Virtu Financial LLC
13F
Company
0.08%
54,823
$43,000 30 Jun 2022
13F
Cambridge Investment Research Advisors, Inc.
13F
Company
0.07%
46,678
$36,000 30 Jun 2022
13F
SeaCrest Wealth Management, LLC
13F
Company
0.06%
40,063
$31,000 30 Jun 2022
13F
Rockefeller Capital Management L.P.
13F
Company
0.06%
40,000
$31,000 30 Jun 2022
13F
Raymond James Financial Services Advisors, Inc.
13F
Company
0.06%
37,450
$29,000 30 Jun 2022
13F
TWO SIGMA SECURITIES, LLC
13F
Company
0.05%
31,142
$24,000 30 Jun 2022
13F
Bank of New York Mellon Corp
13F
Company
0.04%
25,266
$20,000 30 Jun 2022
13F
CAPTRUST FINANCIAL ADVISORS
13F
Company
0.03%
20,000
$16,000 30 Jun 2022
13F
ForthRight Wealth Management, LLC
13F
Company
0.03%
20,000
$16,000 30 Jun 2022
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.03%
19,070
$15,000 30 Jun 2022
13F
LPL Financial LLC
13F
Company
0.02%
15,982
$12,000 30 Jun 2022
13F
Community Bank, N.A.
13F
Company
0.02%
13,226
$10,000 30 Jun 2022
13F
Traynor Capital Management, Inc.
13F
Company
0.02%
11,777
$9,000 30 Jun 2022
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.02%
10,400
$8,000 30 Jun 2022
13F
JANE STREET GROUP, LLC
13F
Company
0.02%
10,396
$8,000 30 Jun 2022
13F
SNS Financial Group, LLC
13F
Company
0.01%
10,000
$8,000 30 Jun 2022
13F
UBS Group AG
13F
Company
0.01%
5,336
$4,000 30 Jun 2022
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
2,048
$2,000 30 Jun 2022
13F
Stephens Consulting, LLC
13F
Company
0%
1,500
$1,170 30 Jun 2022
13F
HOEY INVESTMENTS, INC
13F
Company
0%
1,000
$1,000 30 Jun 2022
13F
American Portfolios Advisors
13F
Company
0%
228
$178 30 Jun 2022
13F
TD Waterhouse Canada Inc.
13F
Company
0%
170
$171 30 Jun 2022
13F
Ellen M. Lintal
3/4/5
Former Chief Financial Officer
class O/S missing
50,000
04 Apr 2022

Institutional Holders of AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) as of Q3 2022

As of 30 Sep 2022, AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,772,330 shares. The largest 10 holders included VANGUARD GROUP INC, MORGAN STANLEY, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Verition Fund Management LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, PRICE T ROWE ASSOCIATES INC /MD/, and NORTHERN TRUST CORP. This page lists 27 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
29
Q3 2022 holders
27
Holder diff
-2
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 Value $ Q3 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .